Arvinas touts healthy volunteer data for Parkinson's disease PROTAC

Unknown, sometimes stigmatized, Parkinson's disease - progressive neurodegenerative disease, characterized by the destruction of certain neurons in the brain and the accumulation of protein clusters toxic to nerve cells - affects 5,000 people in the Rhone (1.8% of patients in France). A few days before World Parkinson's disease day, [...] Read more "More and more young people are affected by Parkinson's disease" assures Sabrina Lebel appeared fi…

5 Parkinson’s Disease Facts

6 Parkinson’s Disease Facts Anonymous (not verified) Fri, 04/04/2025 - 08:09 The outlook for people with Parkinson's disease is improving Brought into the limelight by actor Michael J. Fox, Parkinson's disease affects the body’s ability to control movement.The most prominent signs of Parkinson's disease result from damage to brain cells that produce a neurochemical called dopamine. Dopamine helps people have smooth, coordinated muscle movements…

Arvinas touts healthy volunteer data for Parkinson's disease PROTAC

Arvinas reported early-stage data for its PROTAC program in healthy volunteers, hoping the results will eventually translate to patients with Parkinson’s disease. The data, which were shared Friday morning, represent some of the first information ...

AC Immune reveals positive Phase 2 data from trial in early PD - BioTuesdays

AC Immune (NASDAQ:ACIU) announced additional interim safety and positive immunogenicity data from the Phase 2 VacSYn trial evaluating ACI-7104.056—its anti-alpha-synuclein (a-syn) active immunotherapy candidate—for the treatment of patients with early Parkinson’s disease (PD). According to AC Immune highlights include: active immunotherapy with ACI-7104.056 induces high anti-a-syn antibody levels on average over 20-fold higher than placebo after…

AC Immune reports interim outcomes from trial of Parkinson's therapy

AC Immune has reported additional interim safety and positive immunogenicity outcomes from its placebo-controlled Phase II VacSYn trial.The post AC Immune reports interim outcomes from trial of Parkinson’s therapy appeared first on Clinical Trials Arena.